Results 181 to 190 of about 16,734 (205)

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Andexanet Alfa for Factor Xa Inhibitor Reversal

New England Journal of Medicine, 2016
Birocchi, Simone, Fiorelli, Elisa M, Podda, Gian Marco   +2 more
openaire   +8 more sources

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Ciara C O’sullivan, Grace D Cullen, Grace M Choong   +2 more
exaly  

Andexanet Alfa for Bleeding with Factor Xa Inhibitors

New England Journal of Medicine, 2019
Pamela B. Conley, Stuart J. Connolly, Truman J. Milling   +2 more
openaire   +3 more sources

Thrombin and factor Xa inhibitors

Drugs of the Future, 1998
openaire   +2 more sources

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Barata, Brian I Rini
exaly  

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Ca-A Cancer Journal for Clinicians, 2018
Farhad Islami, Ann Goding Sauer, Kimberly D Miller   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Joyce Slingerland, Manuel Picon-ruiz, Cynthia Morata-tarifa   +2 more
exaly  

An overview of precision oncology basket and umbrella trials for clinicians

Ca-A Cancer Journal for Clinicians, 2020
Edward J Mills, Jay J H Park, Kristian Thorlund   +2 more
exaly  

Antidote to factor Xa inhibitors

Nature Reviews Cardiology, 2015
openaire   +3 more sources